Shopping Cart
Remove All
Your shopping cart is currently empty
Sotigalimab (APX 005) is a monoclonal antibody targeting CD40 with potential antitumor activity and can be used to study metastatic pancreatic cancer and melanoma.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $197 | - | In Stock | |
| 5 mg | $436 | - | In Stock | |
| 10 mg | $687 | - | In Stock | |
| 25 mg | $1,070 | - | In Stock | |
| 50 mg | $1,430 | - | In Stock |
| Description | Sotigalimab (APX 005) is a monoclonal antibody targeting CD40 with potential antitumor activity and can be used to study metastatic pancreatic cancer and melanoma. |
| Synonyms | PYX-107, PYX107, EPI-0050, APX005, APX 005M, APX 005 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2305607-45-6 |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.